17th week of 2020 patent applcation highlights part 8 |
Patent application number | Title | Published |
20200121554 | HEATING SYSTEM FOR A SAUNA AND SAUNA WITH SUCH A HEATING SYSTEM | 2020-04-23 |
20200121555 | Movable Barefoot Massage Grabbing Bar Rack | 2020-04-23 |
20200121556 | SYSTEM AND METHOD FOR GENERATING PRESSURE POINT MAPS BASED ON REMOTE-CONTROLLED HAPTIC-INTERACTIONS | 2020-04-23 |
20200121557 | MEDICINE CONTAINER, HOUSING AND DISPLAY FOR MEDICINE CONTAINER | 2020-04-23 |
20200121558 | Reservoir Devices, Methods and Systems | 2020-04-23 |
20200121559 | INTRAORAL FLUID DELIVERY SYSTEM AND METHOD | 2020-04-23 |
20200121560 | PILL DISPENSING ASSEMBLY AND METHOD OF USE | 2020-04-23 |
20200121561 | EMERGENCY MEDICATION STORAGE DEVICE FOR CARDIAC CHEST PAIN | 2020-04-23 |
20200121562 | RESIN COMPOSITE AND RESTORATION CONTAINING BIOACTIVE GLASS FILLERS | 2020-04-23 |
20200121563 | DENTAL TREATMENT MATERIAL AND DENTAL TREATMENT MATERIAL KIT | 2020-04-23 |
20200121564 | CURABLE COMPOSITION | 2020-04-23 |
20200121565 | Modular Partitioned Skin Exfoliant Applicator | 2020-04-23 |
20200121566 | Methods of Making Solid Stick Antiperspirant Compositions | 2020-04-23 |
20200121567 | COSMETIC COMPOSITION WITH UNIVERSAL OPTICAL CORRECTION | 2020-04-23 |
20200121568 | TOPICAL SKIN FORMULATION | 2020-04-23 |
20200121569 | EMULSION COSMETIC CONTAINING TITANIUM DIOXIDE POWDER | 2020-04-23 |
20200121570 | TEETH WHITENING SYSTEM, COMPOSITIONS AND METHODS | 2020-04-23 |
20200121571 | Stable Metal Ion Containing Compositions | 2020-04-23 |
20200121572 | Oral Care Compositions | 2020-04-23 |
20200121573 | COSMETIC INK, INK JET PRINTING INK AND INK CARTRIDGE CONTAINING COSMETIC INK, COSMETIC SHEET, AND METHOD FOR PRODUCING COSMETIC SHEET | 2020-04-23 |
20200121574 | MOUTHWASH COMPOSITION | 2020-04-23 |
20200121575 | COSMETIC BLENDS | 2020-04-23 |
20200121576 | Oral Care Composition | 2020-04-23 |
20200121577 | SKIN CLEANSING COMPOSITION | 2020-04-23 |
20200121578 | HAIR CONDITIONING COMPOSITION FOR IMPROVED RINSE | 2020-04-23 |
20200121579 | TOPICAL COMPOSITIONS | 2020-04-23 |
20200121580 | SKIN BRIGHTENING COMPOSITION COMPRISING NOVEL GINSENOSIDE | 2020-04-23 |
20200121581 | HAIR CARE COMPOSITIONS | 2020-04-23 |
20200121582 | Ecofriendly Biofilm-Disrupting Antimicrobial Formulations, Their Development, and Their Uses | 2020-04-23 |
20200121583 | Oxydation Dye Delivery Product or Process | 2020-04-23 |
20200121584 | ORGANIC TOOTHPASTE | 2020-04-23 |
20200121585 | Unit for the manufacture of an extract of interest of at least one plant, microorganism and/or fungus | 2020-04-23 |
20200121586 | COMPOSITION COMPRISING CHARCOAL AND AN EXTRACT OR SUBSTANCE OF ASTROCARYUM MURUMURU | 2020-04-23 |
20200121587 | COMPOSITIONS FOR TREATING INFECTIONS | 2020-04-23 |
20200121588 | Method of Providing Subcutaneous Administration of Anti-CD38 Antibodies | 2020-04-23 |
20200121589 | COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF USE THEREOF | 2020-04-23 |
20200121590 | NASAL FOAM VIA CRIBRIFORM PLATE FOR MEDICATION DELIVERY TO THE BRAIN AND/OR BODY AND FOR NASAL MOISTURIZATION AND HYGIENE | 2020-04-23 |
20200121591 | FORMULATIONS FOR TREATMENT OF DRY EYE DISEASE | 2020-04-23 |
20200121592 | Thermo-Responsive Gelling Artificial Lacrima | 2020-04-23 |
20200121593 | INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS | 2020-04-23 |
20200121594 | NOVEL DOSAGE FORM | 2020-04-23 |
20200121595 | LIQUISOFT CAPSULES | 2020-04-23 |
20200121596 | RELOADABLE HYDROGEL SYSTEM FOR TREATING MYOCARDIAL INFARCTION | 2020-04-23 |
20200121597 | Injectable and Shearing-Thinning Microbeads Gel, Use Thereof, and Method for Preparing the Same | 2020-04-23 |
20200121598 | PROGRAMMABLE THERMORESPONSIVE GELS | 2020-04-23 |
20200121599 | STABLE LIQUID COMPOSITION COMPRISING BOTULINUM TOXIN | 2020-04-23 |
20200121600 | VACCINE ADJUVANT FORMULATION | 2020-04-23 |
20200121601 | ENCHOLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS | 2020-04-23 |
20200121602 | THERAPEUTIC NANOPARTICLES AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | 2020-04-23 |
20200121603 | Fine Dry Particulate Adenosine Compositions and Topical Formulations Including the Same | 2020-04-23 |
20200121604 | SOLID FOSMETPANTOTENATE FORMULATIONS | 2020-04-23 |
20200121605 | METHODS AND COMPOSITIONS FOR LOCALIZED INTRADUCTAL DRUG DELIVERY TO THE BREAST AND REGIONAL LYMPH NODES | 2020-04-23 |
20200121606 | ORAL SOLID CANNABINOID FORMULATIONS, METHODS FOR PRODUCING AND USING THEREOF | 2020-04-23 |
20200121607 | NOVEL PHARMACEUTICAL COMPOSITION | 2020-04-23 |
20200121608 | Encased Tamper Resistant Controlled Release Dosage Forms | 2020-04-23 |
20200121609 | PH-Sensitive Starch-Based Microcapsule and Its Preparation Method | 2020-04-23 |
20200121610 | MODIFIED CYCLODEXTRIN COATED MAGNETITE NANOPARTICLES FOR TARGETED DELIVERY OF HYDROPHOBIC DRUGS | 2020-04-23 |
20200121611 | PATCH AND PACKAGE THEREOF | 2020-04-23 |
20200121612 | RUPATADINE-CONTAINING PATCH | 2020-04-23 |
20200121613 | PATCH | 2020-04-23 |
20200121614 | CANNABINOID-INFUSED TRANSPARENT HYDROGEL SKIN PATCH | 2020-04-23 |
20200121615 | TREATING DISEASE AND PROMOTING WEIGHT LOSS BY INHIBITING THE TMA/FMO3/TMAO PATHWAY | 2020-04-23 |
20200121616 | COMPOSITIONS COMPRISING CANNABIDIOL AND HYALURONIC ACID FOR TREATING INFLAMMATORY JOINT DISEASES | 2020-04-23 |
20200121617 | TREATMENT OF VULVAR PAIN | 2020-04-23 |
20200121618 | METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATION AND OXIDATIVE STRESS | 2020-04-23 |
20200121619 | HYDROXYNORKETAMINE FOR THE USE IN THE TREATMENT OF DEPRESSION | 2020-04-23 |
20200121620 | SENOLYTIC COMPOUNDS | 2020-04-23 |
20200121621 | METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS | 2020-04-23 |
20200121622 | COMPOSITIONS, METHODS AND DEVICES FOR FORMING IMPLANTS FROM INJECTED LIQUIDS | 2020-04-23 |
20200121623 | MIXED SALT COMPOSITIONS FOR PRODUCING ELEVATED AND SUSTAINED KETOSIS | 2020-04-23 |
20200121624 | MAGNESIUM COMPOSITIONS AND METHODS OF USE | 2020-04-23 |
20200121625 | COMBINATION OF ELAFIBRANOR OR DERIVATIVES THEREOF WITH AN ANTI-NASH, ANTI-FIBROTIC OR ANTI-CHOLESTATIC AGENT | 2020-04-23 |
20200121626 | LEVODOPA FRACTIONATED DOSE COMPOSITION AND USE | 2020-04-23 |
20200121627 | COMPOSITION COMPRISING AZELAIC ACID OR AS ACTIVE INGREDIENTS FOR MUSCLE STRENGTHENING, DEVELOPMENT, DIFFERENTIATION, REGENERATION OR INHIBITING MUSCLE ATROPHY | 2020-04-23 |
20200121628 | METHODS OF TREATING MIXED DYSLIPIDEMIA | 2020-04-23 |
20200121629 | COMPOSITION, CONTAINING SARPOGRELATE AS ACTIVE INGREDIENT, FOR PREVENTING OR TREATING SENSORINEURAL HEARING LOSS | 2020-04-23 |
20200121630 | METHODS OF REDUCING RLP-C | 2020-04-23 |
20200121631 | HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF | 2020-04-23 |
20200121632 | ARSINOTHRICIN AND METHODS OF TREATING INFECTIONS USING ARSINOTHRICIN | 2020-04-23 |
20200121633 | NITROXYL DONORS WITH IMPROVED THERAPEUTIC INDEX | 2020-04-23 |
20200121634 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASES SUCH AS ASTHMA OR ATOPY INCLUDING BAICALEIN AS ACTIVE INGREDIENT | 2020-04-23 |
20200121635 | ISOFLAVONOID COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | 2020-04-23 |
20200121636 | METHODS AND COMPOSITIONS FOR TREATING BILE ACID DIARRHEA, DIARRHEA ASSOCIATED WITH SMALL INTESTINE RESECTION OR GALLBLADDER REMOVAL, AND SHORT BOWEL SYNDROME | 2020-04-23 |
20200121637 | WATER SOLUBLE COMPOSITIONS COMPRISING PURIFIED CANNABINOIDS | 2020-04-23 |
20200121638 | FORMULATION BASED ON VITAMIN E OR AN ESTER THEREOF FOR TREATING BACTERIAL AND FUNGAL BIOFILMS | 2020-04-23 |
20200121639 | SGLT1/2 INHIBITOR LIK066 FOR TREATING OBESITY | 2020-04-23 |
20200121640 | Compositions and Methods for the Treatment of Metabolic Conditions | 2020-04-23 |
20200121641 | Antiproliferative DNA Polymerase Inhibitor | 2020-04-23 |
20200121642 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH REDUCED CFTR FUNCTION | 2020-04-23 |
20200121643 | FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS | 2020-04-23 |
20200121644 | METHODS OF TREATING SEPSIS WITH SYNAPTIC VESICLE 2A AND/OR 2B BINDING CHEMICAL ENTITIES | 2020-04-23 |
20200121645 | COMPOSITION FOR PREVENTING OR TREATING EGFR-MUTANT NON-SMALL CELL LUNG CANCER | 2020-04-23 |
20200121646 | CHEMICAL COMPOSITIONS AND METHODS FOR ENHANCING TRANSDERMAL DELIVERY OF THERAPEUTIC AGENTS | 2020-04-23 |
20200121647 | SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | 2020-04-23 |
20200121648 | PHARMACEUTICAL COMPOSITION | 2020-04-23 |
20200121649 | PHARMACEUTICAL PREPARATION | 2020-04-23 |
20200121650 | PHARMACEUTICAL COMPOSITION | 2020-04-23 |
20200121651 | Pramipexole for Use in the Treatment of Pain | 2020-04-23 |
20200121652 | COMPOUNDS HAVING CASPASE INHIBITORY ACTIVITY, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS AND FOR TREATING OR PREVENTING CORNEAL ENDOTHELIAL SYMPTOMS, DISORDERS, OR DISEASES, AND APPLICATION OF SAID PHARMACEUTICAL AGENT | 2020-04-23 |
20200121653 | METHODS FOR TREATING IRRITABLE BOWEL SYNDROME (IBS) | 2020-04-23 |